A Pilot Study of Denileukin Diftitox (DD) in Combination With High-dose Interleukin-2 (IL-2) for Patients With Metastatic Renal Cell Carcinoma (RCC)
暂无分享,去创建一个
A. Rademaker | N. Smith | T. Kuzel | G. Macvicar | J. Kozlowski | C. Goolsby | J. Eklund | Lili Wang | A. Gidron | B. Martone | L. Marszalek | Elizabeth Atchison